Auna S.A.: financial analysis
Ratios worked out from 3 fiscal years of Auna S.A.'s statements, compared with 1,214 companies in Healthcare.
Auna S.A. scorecard#
Passes 10 of the 16 checks that could be worked out: strongest in profitability (3 of 4), weakest in financial health (2 of 6). Fiscal year 2024; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth2 of 2
- ✓Revenue grew in the newest year12.9%Revenue up 12.9% in fiscal 2024.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✓Earnings per share grew in the newest year0.43 vs -1.55Diluted EPS 0.43 in fiscal 2024 against -1.55 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability3 of 4
- ✓Profitable in the newest year$29 MNet income $29 M in fiscal 2024.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median17.9%17.9% against Healthcare's median of -7.7% (674 companies).
- ✗Return on equity above 15%7.5%7.5% in fiscal 2024.
- ✓Return on invested capital above 10%12.0%12.0% in fiscal 2024.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health2 of 6
- ✗Short-term assets cover short-term liabilities0.9×Current ratio 0.88 at the end of fiscal 2024.
- ✗Debt below equity2.0×Debt to equity 2.01 at the end of fiscal 2024.
- ✓Net debt below three years of EBITDA2.7×Net debt 2.7 times EBITDA in fiscal 2024.
- ✗Operating income covers interest five times1.2×Operating income 1.2 times interest in fiscal 2024.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2024.
- ✗Altman Z-score outside the distress zone1.05Z-score 1.05 (distress zone) for fiscal 2024.
Shareholder returns3 of 4
- ✓Pays a dividendYesPaid dividends in fiscal 2024.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- ✓Dividends under 75% of net income1.1%Dividends were 1.1% of net income in fiscal 2024.
- ✗Share count up no more than 2% in a year53.7%Diluted shares up 53.7% in fiscal 2024.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- ✓Free cash flow covers dividends and buybacks$154 MFree cash flow $154 M against $0 M paid out in fiscal 2024.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 20, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2024 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Worth a look
- The share count rose 53.7% in the year.
- Operating income covers the interest bill only 1.2 times.
- Liabilities due within a year exceed current assets (current ratio 0.88).
- Goodwill and intangibles ($468 million) exceed shareholders' equity ($394 million).
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseyes
- Cash from operations exceeds profityes
- Long-term debt fell against assetsyes
- Current ratio roseno
- No new shares issuedno
- Gross margin roseyes
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | -0.03 | × 1.2 | -0.04 |
| Retained earnings to assets | -0.04 | × 1.4 | -0.05 |
| Operating income to assets | 0.11 | × 3.3 | 0.37 |
| Market value to liabilities | 0.27 | × 0.6 | 0.16 |
| Revenue to assets | 0.62 | × 1 | 0.62 |
Where the return on equity comes from
The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.
Profitability#
| Fiscal year | Trend | 2024 | 2023 | 2022 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Gross margin | 39.3% | 37.0% | 35.9% | 58.4% | 24% | |
| Operating margin | 17.9% | 14.5% | 10.4% | -7.7% | 86% | |
| Net margin | 2.5% | -6.6% | -3.5% | -8.1% | 65% | |
| Return on equity | 7.5% | -20.3% | -8.0% | -36.9% | 79% | |
| Return on assets | 1.5% | -3.6% | -1.3% | -29.1% | 77% | |
| Return on invested capital | 12.0% | — | — | 11.2% | 54% |
Growth#
| Fiscal year | Trend | 2024 | 2023 | 2022 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Revenue growth | 12.9% | 62.3% | — | 10.2% | 55% |
Financial strength#
| Fiscal year | Trend | 2024 | 2023 | 2022 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Debt to equity | 2.01× | 2.30× | 1.23× | 0.45× | 11% | |
| Net debt | $728 M | $838 M | $286 M | $7 M | 23% | |
| Net debt to EBITDA | 2.72× | 3.94× | 2.80× | 1.78× | 34% | |
| Interest cover | 1.24× | 0.71× | 0.81× | -6.90× | 77% | |
| Current ratio | 0.88× | 0.92× | 0.42× | 3.18× | 13% | |
| Equity share of assets | 20.9% | 19.1% | 16.2% | 55.7% | 22% |
Cash#
| Fiscal year | Trend | 2024 | 2023 | 2022 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Free cash flow | $154 M | $125 M | $16 M | $-11 M | 85% | |
| Free cash flow margin | 13.2% | 12.0% | 2.5% | -1.3% | 78% | |
| Cash conversion | 606.2% | — | — | 147.6% | 97% | |
| Capital spending share of revenue | 2.1% | 3.0% | 4.2% | 2.3% | — |
Efficiency#
| Fiscal year | Trend | 2024 | 2023 | 2022 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Asset turnover | 0.59× | 0.55× | 0.37× | 0.53× | 57% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Dividend yield
- Dividends paid in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Dividend payout
- Dividends paid as a share of net income. Only when the year was profitable.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).